Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening

Analytical Biochemistry

Volumn 412, Issue 1, 2011, Pages 85-91

  Moaddel, R ^a   Rosenberg, A ^a   Spelman, K ^a   Frazier, J ^a   Frazier, C ^a   Nocerino, S ^b   Brizzi, A ^b   Mugnaini, C ^b   Wainer, I W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Basophils; Biochromatography; Cannabinoids; KU 812; Zanthoxylum

Indexed keywords

ACTIVATION ANALYSIS; BINDING ENERGY; CELL CULTURE;

BASOPHILS; BIOCHROMATOGRAPHY; CANNABINOID RECEPTORS; CANNABINOIDS; CHROMATOGRAPHIC TECHNIQUES; CHRONIC MYELOGENOUS LEUKEMIA; THERAPEUTIC TARGETS; ZANTHOXYLUM;

DISEASES;

ALKANOIC ACID; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CARYOPHYLLENE; COTININE; DIPHENHYDRAMINE; DODECADIENOIC ACID ISOBUTYLAMIDE; KETAMINE; METHANANDAMIDE; NICOTINE; UNCLASSIFIED DRUG; WIN 551212;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; ONLINE SYSTEM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN IMMOBILIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; SCREENING TEST; ZANTHOXYLUM;

ZANTHOXYLUM; ZANTHOXYLUM CLAVA-HERCULIS;

EID: 79952439940     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.12.034     Document Type: Article

References (31)

1. D. Shire, B. Calandra, M. Delpech, X. Dumont, M. Kaghad, G. Le Fur, D. Caput, and P. Ferrara Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A J. Biol. Chem. 271 1996 6941 6946 (Pubitemid 26104790)
2. S. Merighi, C. Simioni, S. Gessi, K. Varani, and P.A. Borea Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors Biochem. Pharmacol. 79 2010 471 477
3. V. Tyagi, B.J. Philips, R. Su, M.C. Smaldone, V.L. Erickson, M.B. Chancellor, N. Yoshimura, and P. Tyagi Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium J. Urol. 181 2009 1932 1938
4. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, and P. Carayon Expression of central and cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur. J. Biochem. 232 1995 54 61
5. D. Parolaro, P. Massi, T. Rubino, and E. Monti Endocannabinoids in the immune system and cancer Prostaglandins Leukot. Essent. Fatty Acids 66 2002 319 332 (Pubitemid 34743605)
6. J.M. Derocq, O. Jbilo, M. Bouaboula, M. Segui, C. Clere, and P. Casellas Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60: possible involvement of the CB2 receptor in cell differentiation J. Biol. Chem. 275 2000 15621 15628 (Pubitemid 30366856)
7. R.G. Pertwee The pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol. Ther. 74 1997 129 180 (Pubitemid 27337346)
8. W.Y. Ong, and K. Mackie A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord J. Neurocytol. 28 1999 39 45 (Pubitemid 30040768)
9. K. Mackie Cannabinoid receptors as therapeutic targets Annu. Rev. Pharmacol. Toxicol. 46 2006 101 122
10. D. McGuinness, A. Malikzay, R. Visconti, V. Lin, M. Bayne, F. Monsma, and C.A. Lunn Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter-arrestin assay J. Biomol. Screen. 14 2009 49 58
11. T. Drmota, P. Greasley, T. Groblewski, Screening assays for cannabinoid-ligand-type modulators of GPR55, US patent 2006/0194260 A1 (2006).
12. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International union of pharmacology: XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202 (Pubitemid 34575709)
13. B.L. Faubert Kaplan, C.E. Rockwell, and N.E. Kaminski Evidence for cannabinoid receptor-dependent and-independent mechanisms of action in leukocytes J. Pharmacol. Exp. Ther. 306 2003 1077 1085 (Pubitemid 37025316)
14. R. Moaddel, and I.W. Wainer The preparation and development of cellular membrane affinity chromatography columns Nat. Protoc. 4 2009 197 205
15. R. Moaddel, P. Bullock, and I.W. Wainer Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates J. Chromatogr. B 799 2004 255 263 (Pubitemid 37510228)
16. R. Moaddel, R. Hamid, S. Patel, I.W. Wainer, and P. Bullock Comparison of an open tubular column containing immobilized P-glycoprotein with Caco-2 cell monolayers for the purpose of investigating interactions between drug candidates and Pgp Anal. Chim. Acta 578 2006 25 30
17. R. Silvestri, A. Ligresti, G. La Regina, F. Piscitelli, V. Gatti, A. Brizzi, S. Pasquini, A. Lavecchia, M. Allar, N. Fantini, M.A. Carai, E. Novellino, G. Colombo, V. Di Marzo, and F. Corelli Synthesis, cannabinoid receptor affinity, molecular modeling studies, and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3- carboxamides: 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile Bioorg. Med. Chem. 17 2009 5549 5564
18. R. Silvestri, M.G. Cascio, G. La Regina, F. Piscitelli, A. Lavecchia, A. Brizzi, S. Pasquini, M. Botta, E. Novellino, V. Di Marzo, and F. Corelli Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides J. Med. Chem. 51 2008 1560 1576 (Pubitemid 351438840)
19. A. Brizzi, V. Brizzi, A. Martinelli, T. Tuccinardi, M.G. Cascio, T. Bisogno, and V. Di Marzo Design, synthesis, and molecular modeling studies of new potent ligands of cannabinoid receptors Bioorg. Med. Chem. 15 2007 5406 5416 (Pubitemid 46963002)
20. S. Pasquini, L. Botta, T. Semeraro, C. Mugnaini, A. Ligresti, E. Palazzo, S. Maione, V. Di Marzo, and F. Corelli Investigations on the 4-quinolone-3-carboxylic acid motif: 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo J. Med. Chem. 51 2008 5075 5084
21. A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzma, G. Velasco, and J.L. Iovanna Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cancer Res. 66 2006 6748 6755 (Pubitemid 44085633)
22. T. Kimura, J. Perry, N. Anzai, J. Pritchard, and R. Moaddel Development and characterization of immobilized human organic anion transporter based liquid chromatographic stationary phase: hOAT1 and hOAT2 J. Chromatogr. B 859 2007 267 271 (Pubitemid 350046450)
23. R.A. Ross, H.C. Brockie, L.A. Stevenson, V.L. Murphy, F. Templeton, A. Makriyannis, and R.G. Pertwee Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630 Br. J. Pharmacol. 126 1999 665 672 (Pubitemid 29087845)
24. T. Kitabatake, R. Moaddel, R. Cole, M. Gandhari, C. Frazier, J. Hartenstein, A. Rosenberg, M. Bernier, and I.W. Wainer Characterization of a multiple ligand-gated ion channel cellular membrane affinity chromatography (CMAC) column and identification of endogenously expressed receptors in astrocytoma cell lines Anal. Chem. 80 2008 8673 8680
25. R. Moaddel, K. Jozwiak, R. Yamaguchi, C. Cobello, K. Whittington, T. Sarkar, S. Basak, and I.W. Wainer On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the α3β4 and α4β2-nicotinic acetylcholine receptors using immobilized receptor based liquid chromatographic stationary phases J. Chromatogr. B 813 2004 235 240 (Pubitemid 39535451)
26. E. Calleri, S. Ceruti, G. Cristalli, C. Martini, C. Temporini, C. Parravacini, R. Volpini, S. Daniele, G. Caccialanza, D. Lecca, C. Lambertucci, M.L. Trincavelli, G. Marrucci, I.W. Wainer, G. Ranghino, P. Fantucci, M. Abbracchio, and G. Massolini Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor J. Med. Chem. 53 2010 3489 3501
27. K. Spelman, M.H. Wetschler, and N.B. Cech Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS J. Pharm. Biomed. Anal. 49 2009 1141 1149
28. J. Gertsch, R. Schoop, U. Kuenzle, and A. Suter Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways FEBS Lett. 577 2004 563 569 (Pubitemid 39535349)
29. S. Raduner, A. Majewska, J.-Z. Chen, X.-Q. Xie, J. Hamon, B. Faller, K.-H. Altmann, and J. Gertsch Alkylamides from Echinacea are a new class of cannabinomimetics: cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects J. Biol. Chem. 281 2006 14192 14206 (Pubitemid 43848347)
30. J.Y. Koo, Y. Jang, H. Cho, C.-H. Lee, K.H. Jang, Y.H. Chang, J. Shin, and U. Oh Hydroxy-α-sanshool activates TRPV1 and TRPA1 in sensory neurons Eur. J. Neurosci. 26 2007 1139 1147 (Pubitemid 47346761)
31. C.E. Riera, C. Menozzi-Smarrito, M. Affolter, S. Michlig, C. Munari, F. Robert, H. Vogel, S.A. Simon, and J. Le Coutre Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels Br. J. Pharmacol. 157 2009 1398 1409